We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SF
1151
Stifel
SF
$11.4B
| $921K | ﹤0.01% |
23,156
-522
| -2% | -$20.4K |
|
1152
Encompass Health
EHC
$12.2B
| $921K | ﹤0.01% |
13,597
-288
| -2% | -$18K |
|
1153
Ardagh Metal Packaging
AMBP
$2.82B
| $920K | ﹤0.01% |
244,605
+1,865
| +0.8% | +$6.89K |
|
1154
NOV
NOV
$7.33B
| $919K | ﹤0.01% |
57,322
+8,702
| +18% | +$142K |
|
1155
HealthEquity
HQY
$7.94B
| $918K | ﹤0.01% |
14,544
-260
| -2% | -$15.1K |
|
1156
Harmonic Inc
HLIT
$1.22B
| $911K | ﹤0.01% |
56,326
-3,234
| -5% | -$51.9K |
|
1157
Willis Towers Watson
WTW
$29.1B
| $905K | ﹤0.01% |
3,844
+2,215
| +136% | +$510K |
|
1158
Nexstar Media Group
NXST
$5.04B
| $905K | ﹤0.01% |
5,432
-359
| -6% | -$59.5K |
|
1159
Royal Gold
RGLD
$20.8B
| $905K | ﹤0.01% |
7,881
-375
| -5% | -$48.3K |
|
1160
Alcoa
AA
$12.2B
| $900K | ﹤0.01% |
26,526
-1,469
| -5% | -$53.4K |
|
1161
Progyny
PGNY
$2.1B
| $900K | ﹤0.01% |
22,877
-847
| -4% | -$30.6K |
|
1162
Valvoline
VVV
$3.46B
| $893K | ﹤0.01% |
23,798
-1,926
| -7% | -$69.9K |
|
1163
H&R Block
HRB
$5.56B
| $892K | ﹤0.01% |
27,999
-61,570
| -69% | -$1.99M |
|
|
MRNS
1164
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $890K | ﹤0.01% |
+81,964
| New | +$702K |
|
1165
Agree Realty
ADC
$8.52B
| $888K | ﹤0.01% |
13,576
+308
| +2% | +$20.4K |
|
1166
BWX Technologies
BWXT
$13.3B
| $886K | ﹤0.01% |
12,383
-15,134
| -55% | -$989K |
|
1167
Polaris
PII
$3.15B
| $885K | ﹤0.01% |
7,321
-471
| -6% | -$52.1K |
|
1168
GlobalFoundries
GFS
$24B
| $883K | ﹤0.01% |
13,677
-1,359
| -9% | -$82.2K |
|
1169
Akebia Therapeutics
AKBA
$254M
| $883K | ﹤0.01% |
965,193
-54,839
| -5% | -$52.9K |
|
1170
Starwood Property Trust
STWD
$5.55B
| $882K | ﹤0.01% |
45,478
+346
| +0.8% | +$6.15K |
|
1171
Extra Space Storage
EXR
$28.8B
| $881K | ﹤0.01% |
5,917
-83,071
| -93% | -$12.5M |
|
1172
Nomad Foods
NOMD
$1.54B
| $873K | ﹤0.01% |
49,835
+10,000
| +25% | +$182K |
|
|
IAS
1173
DELISTED
Integral Ad Science
IAS
| $871K | ﹤0.01% |
+48,430
| New | +$818K |
|
1174
Hexcel
HXL
$6.89B
| $868K | ﹤0.01% |
11,424
+1,425
| +14% | +$102K |
|
1175
RH
RH
$2.4B
| $865K | ﹤0.01% |
2,623
-690
| -21% | -$180K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.